Metex



Indications and Reactions:

Role Indications Reactions
Primary
Rheumatoid Arthritis 30.0%
Atrial Fibrillation 20.0%
Hypertension 20.0%
Blood Folate Decreased 10.0%
Hyperuricaemia 10.0%
Prophylaxis Against Gastrointestinal Ulcer 10.0%
Haemorrhage 100.0%
Secondary
Rheumatoid Arthritis 63.5%
Product Used For Unknown Indication 5.0%
Osteoporosis Prophylaxis 4.5%
Osteoporosis 3.5%
Hypertension 3.0%
Burkitt's Lymphoma 2.5%
Hodgkin's Disease Mixed Cellularity Stage Unspecified 2.0%
Juvenile Arthritis 2.0%
Psoriasis 2.0%
Psoriatic Arthropathy 2.0%
Juvenile Idiopathic Arthritis 1.5%
Mental Disorder 1.5%
Antibiotic Prophylaxis 1.0%
Drug Toxicity Prophylaxis 1.0%
Drug Use For Unknown Indication 1.0%
Pain 1.0%
Prophylaxis 1.0%
Thrombosis Prophylaxis 1.0%
Acne 0.5%
Asthma 0.5%
Pulmonary Fibrosis 12.1%
Renal Cancer 12.1%
Colon Cancer 6.1%
Pancytopenia 6.1%
Postoperative Wound Infection 6.1%
Saliva Altered 6.1%
Sepsis 6.1%
Skin Erosion 6.1%
Subileus 6.1%
Abdominal Hernia 3.0%
Abdominal Pain 3.0%
Diarrhoea 3.0%
Erysipelas 3.0%
Flatulence 3.0%
Inappropriate Schedule Of Drug Administration 3.0%
Migraine 3.0%
Neoplasm 3.0%
Pancreatitis 3.0%
Pleural Effusion 3.0%
Pulmonary Function Test Decreased 3.0%
Concomitant
Rheumatoid Arthritis 33.5%
Product Used For Unknown Indication 20.2%
Drug Use For Unknown Indication 18.3%
Hypertension 4.1%
Polyarthritis 3.3%
Osteoporosis 2.8%
Crohn's Disease 2.7%
Psoriatic Arthropathy 2.7%
Diabetes Mellitus 1.7%
Juvenile Idiopathic Arthritis 1.3%
Osteoporosis Prophylaxis 1.3%
Arthralgia 0.9%
Asthma 0.9%
Back Pain 0.9%
Gastroenteritis 0.9%
Hypertonia 0.9%
Prophylaxis 0.9%
Spondylitis 0.9%
Vitamin Supplementation 0.9%
Ankylosing Spondylitis 0.8%
Urticaria 10.3%
Weight Decreased 8.8%
Osteoarthritis 7.4%
Psoriasis 7.4%
Respiratory Failure 7.4%
Cervix Carcinoma Stage 0 5.9%
Nasopharyngitis 5.9%
Tuberculosis 5.9%
Pulmonary Tuberculosis 4.4%
Tendon Rupture 4.4%
Transaminases Increased 4.4%
Traumatic Brain Injury 4.4%
B-cell Lymphoma 2.9%
Bursitis 2.9%
Endometrial Adenocarcinoma 2.9%
Myelodysplastic Syndrome 2.9%
Oedematous Pancreatitis 2.9%
Ophthalmic Herpes Zoster 2.9%
Pancreatitis Chronic 2.9%
Pleural Effusion 2.9%
Interacting
Rheumatoid Arthritis 42.9%
Hypertension 28.6%
Osteoporosis 14.3%
Prophylaxis Against Gastrointestinal Ulcer 14.3%
Implant Site Effusion 40.0%
Tracheobronchitis 40.0%
Helicobacter Infection 20.0%